stockrowOrganon & Co.
OGNHealthcare Drug Manufacturers General
Organon & Co.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, down 2.92% from fiscal 2024.
- Revenue
- −1.75%
- EPS
- +1.64%
- Free cash flow
- +118.8%
- Total debt
- −3.10%
Quarter to September 2026, against a year earlier
Follow OGN
Alert me
Organon & Co. (OGN) Operating margin
Organon & Co.'s operating margin over the twelve months to 30 September 2026 was 13.6%, up 0.4 percentage points from fiscal 2025 (13.3%). Over the past ten years it has ranged from 13.3% (fiscal 2025) to 62.3% (fiscal 2017) — the current reading is the lowest in ten years. That is below the Drug Manufacturers General industry median of 18.3% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 13.3% | (8.20) |
| FY2024 | 21.5% | 1.39 |
| FY2023 | 20.1% | (5.36) |
| FY2022 | 25.4% | (2.98) |
| FY2021 | 28.4% | (14.39) |
| FY2020 | 42.8% | (4.72) |
| FY2019 | 47.5% | 19.61 |
| FY2018 | 27.9% | (34.41) |
| FY2017 | 62.3% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 23.2% | 2.52 |
| Jun 2026 | 20.7% | 4.57 |
| Mar 2026 | 16.1% | 22.14 |
| Dec 2025 | −6.04% | (28.39) |
| 23 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVO Novo Nordisk A/S compare | 42.7% |
| BMY Bristol Myers Squibb Company compare | 22.7% |
| PFE Pfizer Inc. compare | 21.4% |
| SNY Sanofi compare | 18.7% |
| GSK GSK PLC Sponsored ADR compare | 18.0% |
| GRFS Grifols, S.A. compare | 16.7% |
| OGN Organon & Co. | 13.6% |
| BIIB Biogen Inc. compare | 7.53% |
| AMRN Amarin Corporation PLC compare | −18.2% |
| Drug Manufacturers General industry median | 18.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on OGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement